Abcam (Group)

https://www.abcam.com

Abcam plc is a global leader in the supply of life science research tools, with a wide range of products and expert technical support, enabling scientists to analyse living cells at the molecular level and to improve the understanding of health and disease. Abcam is committed to providing scientists with an extensive choice of reagents and tools, with the most comprehensive, honest and up-to-date datasheets and customer reviews, fast delivery and helpful customer service & technical support. The Company’s catalogue evolves with scientific research trends and is growing each year to provide customers with products to meet their research needs. The range now includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam also supports its customers by hosting a range of global scientific events, forums and webinars, providing opportunities for scientists to get together and present their work. Headquartered in Cambridge, UK, Abcam has nine global subsidiary offices enabling local services and multi-language support to over 100 countries. The Company was founded in 1998, and now employs over 800 people. Abcam was admitted to AIM in 2005 (AIM: ABC). *

	Start	1998-01-01 splitoff predec
	Today	Abcam plc (AIM: ABC, Nasdaq: ABCM)
	Predecessor	Abcam Ltd.
	Industry	research antibody
	Person	Hirzel, Alan (Abcam 201409– CEO before Chief Marketing Officer)
	Person 2	Milner, Jonathan (Abcam 201409 Deputy Chairman + largest shareholder before CEO + Co-founder)

	Region	Cambridge, Cambridgeshire
	Country	United Kingdom (GB)
	Street	Cambridge Science Park
	City	CB4 0FW Cambridge
	Tel	+44-1223-696000
		Address record changed: 2020-12-02

Basic data	Employees	F: 1,001 to 5,000 (2020-10-19)
	Currency	GBP
	Annual sales	260,000,000 (revenue (2019/20) 2020-06-30)
	Profit	12,500,000 (2020-06-30)
	Cash	291,600,000 (2020-06-30)

		* Document for ï¿½About Sectionï¿½:

		Record changed: 2020-10-23